Document is current

Article History

Accepted: 6 February 2025

First Online: 19 February 2025

Declarations

:

: This article does not contain any studies with human or animal subjects performed by any of the authors.

: Avirup Guha discloses the following: (1) consulting fees from Pfizer, Novartis, and Myovant; and (2) ZERO Prostate Cancer – health equity task force, and Doctorpedia – founding medical partner.Morteza Mahmoudi discloses that (1) he is a co-founder and director of the Academic Parity Movement (www.paritymovement.org), a non-profit organization dedicated to addressing academic discrimination, violence and incivility; (2) he is a co-founder of Targets’ Tip and Albuderm; and (3) he receives royalties/honoraria for his published books, plenary lectures, and licensed patents.Sadeer Al-Kindi discloses the following: (1) grants or contracts from Ionis Pharmaceuticals and the National Institutes of Health; and (2) consulting fees from Heartflow Inc.; (3) Member of the AirPressureNYC trial; and (4) Patents planned, issued, or pending for: DEEP-LEARNING-BASED HEPATIC FAT ASSESSMENT, Major adverse cardiovascular event risk prediction based on comprehensive analysis of ct calcium score exam, Prediction of major adverse cardiovascular events (mace) from a.i. analysis of pericoronary fat in CT images, Prediction of stent expansion using finite element modeling and machine learning, and Prediction of stent expansion for treatments.Anant Madabhushi disclosures the following: (1) two different R01 grants with Inspirata Inc.; (2) licenses to Picture Health and Elucid Bioimaging; (3) consulting fees from Takeda Inc.; (4) Frederick National Laboratory Advisory Committee – member; (5) Advisory board of Picture Health and SimBioSys; (6) Stock or stock options for Picture Health, Elucid Bioimaging, and Inspirata Inc.; and (7) Sponsored research agreements with AstraZeneca and Bristol Myers Squibb.The other authors declare that they have no conflict of interest.